These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

649 related items for PubMed ID: 25227898

  • 1. A dosimetric comparison of ultra-hypofractionated passively scattered proton radiotherapy and stereotactic body radiotherapy (SBRT) in the definitive treatment of localized prostate cancer.
    Kole TP, Nichols RC, Lei S, Wu B, Huh SN, Morris CG, Lee S, Tong M, Mendenhall NP, Dritschilo A, Collins SP.
    Acta Oncol; 2015 Jun; 54(6):825-31. PubMed ID: 25227898
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Proton radiotherapy for pediatric bladder/prostate rhabdomyosarcoma: clinical outcomes and dosimetry compared to intensity-modulated radiation therapy.
    Cotter SE, Herrup DA, Friedmann A, Macdonald SM, Pieretti RV, Robinson G, Adams J, Tarbell NJ, Yock TI.
    Int J Radiat Oncol Biol Phys; 2011 Dec 01; 81(5):1367-73. PubMed ID: 20934266
    [Abstract] [Full Text] [Related]

  • 4. Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations.
    Fuller DB, Naitoh J, Lee C, Hardy S, Jin H.
    Int J Radiat Oncol Biol Phys; 2008 Apr 01; 70(5):1588-97. PubMed ID: 18374232
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparing photon and proton-based hypofractioned SBRT for prostate cancer accounting for robustness and realistic treatment deliverability.
    Goddard LC, Brodin NP, Bodner WR, Garg MK, Tomé WA.
    Br J Radiol; 2018 May 01; 91(1085):20180010. PubMed ID: 29436852
    [Abstract] [Full Text] [Related]

  • 10. A treatment planning study comparing IMRT techniques and cyber knife for stereotactic body radiotherapy of low-risk prostate carcinoma.
    Scobioala S, Kittel C, Elsayad K, Kroeger K, Oertel M, Samhouri L, Haverkamp U, Eich HT.
    Radiat Oncol; 2019 Aug 09; 14(1):143. PubMed ID: 31399115
    [Abstract] [Full Text] [Related]

  • 11. Dosimetric feasibility of moderately hypofractionated/dose escalated radiation therapy for localised prostate cancer with intensity-modulated proton beam therapy using simultaneous integrated boost (SIB-IMPT) and impact of hydrogel prostate-rectum spacer.
    Ahmad Khalil D, Jazmati D, Geismar D, Wulff J, Bäumer C, Kramer PH, Steinmeier T, Schulze Schleitthoff S, Plaude S, Bischoff M, Tschirdewahn S, Hadaschik B, Timmermann B.
    Radiat Oncol; 2022 Apr 01; 17(1):64. PubMed ID: 35365170
    [Abstract] [Full Text] [Related]

  • 12. Dosimetric and radiobiological impact of intensity modulated proton therapy and RapidArc planning for high-risk prostate cancer with seminal vesicles.
    Rana S, Cheng C, Zhao L, Park S, Larson G, Vargas C, Dunn M, Zheng Y.
    J Med Radiat Sci; 2017 Mar 01; 64(1):18-24. PubMed ID: 27741379
    [Abstract] [Full Text] [Related]

  • 13. Dosimetric and radiobiological comparison of Cyberknife and Tomotherapy in stereotactic body radiotherapy for localized prostate cancer.
    Chen CY, Lee LM, Yu HW, Lee SP, Lee HL, Lin YW, Wen YC, Chen YJ, Chen CP, Tsai JT.
    J Xray Sci Technol; 2017 Mar 01; 25(3):465-477. PubMed ID: 28157113
    [Abstract] [Full Text] [Related]

  • 14. Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis.
    Macdonald OK, Kruse JJ, Miller JM, Garces YI, Brown PD, Miller RC, Foote RL.
    Int J Radiat Oncol Biol Phys; 2009 Nov 01; 75(3):950-8. PubMed ID: 19801106
    [Abstract] [Full Text] [Related]

  • 15. Helical tomotherapy and intensity modulated proton therapy in the treatment of dominant intraprostatic lesion: a treament planning comparison.
    Fellin F, Azzeroni R, Maggio A, Lorentini S, Cozzarini C, Di Muzio N, Fiorino C, Calandrino R, Schwarz M.
    Radiother Oncol; 2013 May 01; 107(2):207-12. PubMed ID: 23541644
    [Abstract] [Full Text] [Related]

  • 16. Real-world dosimetric comparison between CyberKnife SBRT and HDR brachytherapy for the treatment of prostate cancer.
    Chatzikonstantinou G, Keller C, Scherf C, Bathen B, Köhn J, Tselis N.
    Brachytherapy; 2021 May 01; 20(1):44-49. PubMed ID: 32826171
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dose painting to treat single-lobe prostate cancer with hypofractionated high-dose radiation using targeted external beam radiation: Is it feasible?
    Amini A, Westerly DC, Waxweiler TV, Ryan N, Raben D.
    Med Dosim; 2015 May 01; 40(3):256-61. PubMed ID: 25824420
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.